The combined stimulation was again a more potent IL-6 inducer than BCR-cross-linking alone (anti-BCR; HD: 115.5 ± 80.4 pg/ml; SLE: 153.8 ± 109.8 pg/ml). The gene discussed is IL6; the disease is Huntington disease.